Systems for vendor development in pharmaceuticals as per current good manufacturing practices

Vasanthi, N. Abhinaya, B. S. Muddukrishna, Shrikumara, K. Girish Pai

Research output: Contribution to journalArticle

Abstract

A Pharmaceutical company has to buy a range of different components and raw materials for production from various upstream vendors. Choosing the right vendor among the existing vendors, monitoring their performance is a major challenge for Pharmaceuticals. The vendor development is an important strategic process carried out in every pharmaceutical industry in accordance with current and justifiable rules and regulations, inefficiency of which affects the quality and safety of pharmaceutical products. Even after considering it as an important process many pharmaceuticals fail to follow, due to inadequate time, price, and logistics issues. Quality Assurance and Quality Control department helps to ensure that the material supplied by the vendors meets the required specification requirements. Thus, a Quality department and supply chain considered to be right departments to choose the right vendor for the Quality of raw material for the production of a pharmaceutical product. Furthermore, the FDA (Food and drug administration) has issued several guidelines on current good manufacturing practices to assure that processes for the packaging material, raw material, labeling and storage of additives are documented and meet specification requirements to assure material purity, potency, and quality. We place the contribution in a conceptual framework that takes into consideration the diversity of supply chain situations in terms of complexity and significance; it covers up all phases of the vendor development process, from the basic definition of problems to the qualification of the potential vendor to the final selection of vendors. And also the final suitable decision methods reported in this literature to support the selection process for the vendors.

Original languageEnglish
Pages (from-to)4879-4888
Number of pages10
JournalResearch Journal of Pharmacy and Technology
Volume12
Issue number10
DOIs
Publication statusPublished - 10-2019

Fingerprint

Pharmaceutical Preparations
Drug Industry
Product Packaging
United States Food and Drug Administration
Quality Control
Guidelines
Safety

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)

Cite this

@article{b26d1806b4cc44658b45b6a0d462f3f0,
title = "Systems for vendor development in pharmaceuticals as per current good manufacturing practices",
abstract = "A Pharmaceutical company has to buy a range of different components and raw materials for production from various upstream vendors. Choosing the right vendor among the existing vendors, monitoring their performance is a major challenge for Pharmaceuticals. The vendor development is an important strategic process carried out in every pharmaceutical industry in accordance with current and justifiable rules and regulations, inefficiency of which affects the quality and safety of pharmaceutical products. Even after considering it as an important process many pharmaceuticals fail to follow, due to inadequate time, price, and logistics issues. Quality Assurance and Quality Control department helps to ensure that the material supplied by the vendors meets the required specification requirements. Thus, a Quality department and supply chain considered to be right departments to choose the right vendor for the Quality of raw material for the production of a pharmaceutical product. Furthermore, the FDA (Food and drug administration) has issued several guidelines on current good manufacturing practices to assure that processes for the packaging material, raw material, labeling and storage of additives are documented and meet specification requirements to assure material purity, potency, and quality. We place the contribution in a conceptual framework that takes into consideration the diversity of supply chain situations in terms of complexity and significance; it covers up all phases of the vendor development process, from the basic definition of problems to the qualification of the potential vendor to the final selection of vendors. And also the final suitable decision methods reported in this literature to support the selection process for the vendors.",
author = "Vasanthi and N. Abhinaya and Muddukrishna, {B. S.} and Shrikumara and {Girish Pai}, K.",
year = "2019",
month = "10",
doi = "10.5958/0974-360X.2019.00845.X",
language = "English",
volume = "12",
pages = "4879--4888",
journal = "Research Journal of Pharmacy and Technology",
issn = "0974-3618",
publisher = "A and V Publication",
number = "10",

}

Systems for vendor development in pharmaceuticals as per current good manufacturing practices. / Vasanthi; Abhinaya, N.; Muddukrishna, B. S.; Shrikumara, ; Girish Pai, K.

In: Research Journal of Pharmacy and Technology, Vol. 12, No. 10, 10.2019, p. 4879-4888.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systems for vendor development in pharmaceuticals as per current good manufacturing practices

AU - Vasanthi,

AU - Abhinaya, N.

AU - Muddukrishna, B. S.

AU - Shrikumara,

AU - Girish Pai, K.

PY - 2019/10

Y1 - 2019/10

N2 - A Pharmaceutical company has to buy a range of different components and raw materials for production from various upstream vendors. Choosing the right vendor among the existing vendors, monitoring their performance is a major challenge for Pharmaceuticals. The vendor development is an important strategic process carried out in every pharmaceutical industry in accordance with current and justifiable rules and regulations, inefficiency of which affects the quality and safety of pharmaceutical products. Even after considering it as an important process many pharmaceuticals fail to follow, due to inadequate time, price, and logistics issues. Quality Assurance and Quality Control department helps to ensure that the material supplied by the vendors meets the required specification requirements. Thus, a Quality department and supply chain considered to be right departments to choose the right vendor for the Quality of raw material for the production of a pharmaceutical product. Furthermore, the FDA (Food and drug administration) has issued several guidelines on current good manufacturing practices to assure that processes for the packaging material, raw material, labeling and storage of additives are documented and meet specification requirements to assure material purity, potency, and quality. We place the contribution in a conceptual framework that takes into consideration the diversity of supply chain situations in terms of complexity and significance; it covers up all phases of the vendor development process, from the basic definition of problems to the qualification of the potential vendor to the final selection of vendors. And also the final suitable decision methods reported in this literature to support the selection process for the vendors.

AB - A Pharmaceutical company has to buy a range of different components and raw materials for production from various upstream vendors. Choosing the right vendor among the existing vendors, monitoring their performance is a major challenge for Pharmaceuticals. The vendor development is an important strategic process carried out in every pharmaceutical industry in accordance with current and justifiable rules and regulations, inefficiency of which affects the quality and safety of pharmaceutical products. Even after considering it as an important process many pharmaceuticals fail to follow, due to inadequate time, price, and logistics issues. Quality Assurance and Quality Control department helps to ensure that the material supplied by the vendors meets the required specification requirements. Thus, a Quality department and supply chain considered to be right departments to choose the right vendor for the Quality of raw material for the production of a pharmaceutical product. Furthermore, the FDA (Food and drug administration) has issued several guidelines on current good manufacturing practices to assure that processes for the packaging material, raw material, labeling and storage of additives are documented and meet specification requirements to assure material purity, potency, and quality. We place the contribution in a conceptual framework that takes into consideration the diversity of supply chain situations in terms of complexity and significance; it covers up all phases of the vendor development process, from the basic definition of problems to the qualification of the potential vendor to the final selection of vendors. And also the final suitable decision methods reported in this literature to support the selection process for the vendors.

UR - http://www.scopus.com/inward/record.url?scp=85075251043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075251043&partnerID=8YFLogxK

U2 - 10.5958/0974-360X.2019.00845.X

DO - 10.5958/0974-360X.2019.00845.X

M3 - Article

AN - SCOPUS:85075251043

VL - 12

SP - 4879

EP - 4888

JO - Research Journal of Pharmacy and Technology

JF - Research Journal of Pharmacy and Technology

SN - 0974-3618

IS - 10

ER -